Bridgeport is a clinical research site located in Bridgeport, Connecticut, United States 06610.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Bridgeport has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection.
Sponsors: Finch Research and Development LLC., SoniVie Inc..
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Bridgeport has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Bridgeport has 3 clinical trials on record, with 1 currently active. Their work covers Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection.
Bridgeport has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.